Dr. Devalingam Mahalingam, MBBChBAO
Claim this profileNorthwestern University
Studies Solid Tumors
Studies Tumors
17 reported clinical trials
53 drugs studied
Area of expertise
1Solid Tumors
Stage IV
PTEN positive
PIK3CA positive
2Tumors
Stage IV
PTEN positive
PIK3CA positive
Affiliated Hospitals
Clinical Trials Devalingam Mahalingam, MBBChBAO is currently running
Tazemetostat
for Advanced Cancer with Liver Impairment
This trial tests tazemetostat, an oral medication, in patients with advanced solid tumors and different liver functions. It aims to understand how the drug behaves in the body and its safety. Researchers will measure drug levels in the blood and monitor for side effects. Tazemetostat is approved by the FDA for certain types of cancer.
Recruiting1 award Phase 1
²¹²Pb-DOTAM-GRPR1
for Cancer
A Phase 1 SAD/MAD dose escalation and expansion study to determine the safety and effectiveness of ²¹²Pb-DOTAM-GRPR1 in subjects with various GRPR-expressing Tumors
Recruiting1 award Phase 16 criteria
More about Devalingam Mahalingam, MBBChBAO
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Devalingam Mahalingam, MBBChBAO has experience with
- Hydroxychloroquine
- Fluorouracil
- Sotorasib
- Olaparib
- Binimetinib
- Palbociclib
Breakdown of trials Devalingam Mahalingam, MBBChBAO has run
Solid Tumors
Tumors
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Devalingam Mahalingam, MBBChBAO specialize in?
Devalingam Mahalingam, MBBChBAO focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are PTEN positive.
Is Devalingam Mahalingam, MBBChBAO currently recruiting for clinical trials?
Yes, Devalingam Mahalingam, MBBChBAO is currently recruiting for 8 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Devalingam Mahalingam, MBBChBAO has studied deeply?
Yes, Devalingam Mahalingam, MBBChBAO has studied treatments such as Hydroxychloroquine, Fluorouracil, Sotorasib.
What is the best way to schedule an appointment with Devalingam Mahalingam, MBBChBAO?
Apply for one of the trials that Devalingam Mahalingam, MBBChBAO is conducting.
What is the office address of Devalingam Mahalingam, MBBChBAO?
The office of Devalingam Mahalingam, MBBChBAO is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.